Search results for "units"

showing 10 items of 576 documents

Multiple actions of fenamates and other nonsteroidal anti-inflammatory drugs on GABAA receptors

2019

The nonsteroidal anti-inflammatory drug (NSAID) niflumic acid, a fenamate in structure, has many molecular targets, one of them being specific subtypes of the main inhibitory ligand-gated anion channel, the GABA(A) receptor. Here, we report on the effects of other fenamates and other classes of NSAIDs on brain picrotoxinin-sensitive GABA A receptors, using an autoradiographic assay with [S-35]TBPS as a ligand on mouse brain sections. We found that the other fenamates studied (flufenamic acid, meclofenamic acid, mefenamic acid and tolfenamic acid) affected the autoradiographic signal at low micromolar concentrations in a facilitatory-like allosteric fashion, i.e., without having affinity to …

MECHANISM0301 basic medicineNSAID drugsMefenamic acidAllosteric regulationPharmacologyBINDING-SITESGABA03 medical and health sciences0302 clinical medicineTolfenamic acidNiflumic acidmedicineSHIFTMODULATIONReceptorXenopus oocytesAGENTPharmacologyChemistryGABAA receptorNiflumic acidANION GRADIENTA RECEPTORSSUBUNITS3. Good healthMeclofenamic acidFenamates030104 developmental biologyFlufenamic acid317 PharmacyACIDAutoradiography030217 neurology & neurosurgeryRecombinant GABA(A) receptorsRESPONSESmedicine.drugEuropean Journal of Pharmacology
researchProduct

Breathing-Dependent Redox Activity in a Tetrathiafulvalene-Based Metal–Organic Framework

2018

"Breathing" metal-organic frameworks (MOFs) that involve changes in their structural and physical properties upon an external stimulus are an interesting class of crystalline materials due to their range of potential applications including chemical sensors. The addition of redox activity opens up a new pathway for multifunctional "breathing" frameworks. Herein, we report the continuous breathing behavior of a tetrathiafulvalene (TTF)-based MOF, namely MUV-2, showing a reversible swelling (up to ca. 40% of the volume cell) upon solvent adsorption. Importantly, the planarity of the TTF linkers is influenced by the breathing behavior of the MOF, directly impacting on its electrochemical proper…

MECHANISMNIChemistry MultidisciplinarySOLIDSQuímica organometàl·lica010402 general chemistryElectrochemistry01 natural sciencesBiochemistryArticleCatalysisMOFSRedox Activitychemistry.chemical_compoundsymbols.namesakeColloid and Surface ChemistryAdsorptionReacció d'oxidació-reduccióCATIONCONDUCTIVITYQuantum chemicalScience & Technology010405 organic chemistryUNITSGeneral Chemistry0104 chemical sciencesSolventChemistryChemical engineeringchemistryHYBRID FRAMEWORKSPhysical SciencessymbolsMetal-organic frameworkRaman spectroscopy03 Chemical SciencesTetrathiafulvaleneJournal of the American Chemical Society
researchProduct

8-Azido-adenosine 5'-triphosphate as a Photoaffinity Label for Bacterial F1 ATPase

1978

1. 8-Azido-adenosine 5'-triphosphate (n83ATP) is a suitable photoaffinity label for F1 ATPase from Micrococcus luteus. The nucleotide is a substrate in the presence of bivalent cations and inhibits the enzyme irreversibly upon irradiation with ultraviolet light above 300 nm. 2. More than 80% of the label is covalently bound to the beta subunits in the presence of bivalent cations. Labeling and inactivation is decreased by protection with ADP, ATP or adenyl-5'-yl imidodiphosphate. To a much smaller degree the alpha subunits also become labeled. 3. n83AMP does not specifically bind to the beta subunits upon irradiation. Like n83ATP and n83ADP, it also labels the alpha subunits to a small exte…

Macromolecular SubstancesUltraviolet RaysATPaseAffinity labelCooperativityBiochemistryMicrococcuschemistry.chemical_compoundAdenosine TriphosphateAdenine nucleotideUltraviolet lightMagnesiumNucleotideEdetic AcidAdenosine Triphosphataseschemistry.chemical_classificationPhotolysisbiologyAdenine NucleotidesChemistryAffinity LabelsBiochemistrybiology.proteinCalciumAdenosine triphosphateATP synthase alpha/beta subunitsEuropean Journal of Biochemistry
researchProduct

Tumor necrosis factor (TNF)-alpha but not TNF-beta induces secretion of colony stimulating factor for macrophages (CSF-1) by human monocytes

1987

Abstract Tumor necrosis factor (TNF)-alpha has been identified as a major inducer of colony stimulating factor (CSF)-secretion by human vascular endothelial cells and fibroblasts. In the present study we assessed the capacity of TNFs to induce release of CSF-1 from highly purified peripheral blood monocyte preparations. Whereas monocytes do not accumulate CSF-1 messenger (m)RNA constitutively and consequently do not produce CSF-1 protein, CSF-1 mRNA and protein secretion became detectable, when monocytes were cultured in the presence of TNF-alpha, that was synergistically enhanced by interferon-gamma (IFN-gamma). However, under identical experimental conditions TNF-beta failed to induce mon…

Macrophage colony-stimulating factormedicine.medical_specialtyT-LymphocytesImmunologyIn Vitro TechniquesBiologyBiochemistryMonocytesColony-Forming Units AssayColony-Stimulating FactorsInternal medicinemedicineHumansSecretionLeukapheresisMessenger RNATumor Necrosis Factor-alphaMonocyteCell BiologyHematologyMacrophage ActivationColony-stimulating factorMolecular biologyHaematopoiesisEndocrinologySecretory proteinmedicine.anatomical_structureTumor necrosis factor alphaBlood
researchProduct

Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection

2021

Summary Objective To determine the incidence, characteristics, and risk factors of pulmonary embolism (PE) among patients hospitalized for COVID-19. Patients and Methods We performed a prospective observational study of a randomly selected cohort of consecutive patients hospitalized for COVID-19 infection between March 8, 2020 through April 25, 2020. All eligible patients underwent a computed tomography pulmonary angiography independently of their PE clinical suspicion and were pre-screened for a baseline elevated D-dimer level. Results 119 patients were randomly selected from the 372 admitted to one tertiary hospital in Valencia (Spain) for COVID-19 infection during the period of study. Se…

Male0301 basic medicineCTPA Computed tomography pulmonary angiographyAUC-ROC Area under curve ROCPCR polymerase chain reaction0302 clinical medicineRisk FactorsspO2 Oxygen saturationIL6 Interleukin-6Pulmonary angiographySD Standard deviationMedicineProspective Studies030212 general & internal medicineProspective cohort studyComputed tomographyFramingham Risk ScoreIncidenceIncidence (epidemiology)RV Right ventricleHazard ratioVenous ThromboembolismMiddle AgedAo Aortic arteryPulmonary embolismCXR chest X-rayHospitalizationInfectious DiseasesCohortCRP C-reactive proteinFemalePA Pulmonary artery trunkMicrobiology (medical)medicine.medical_specialty030106 microbiologysPESI Simplified Pulmonary Embolism Severity IndexBMI Body mass indexPE Pulmonary embolismLV Left ventricleVTE Venous thromboembolismFibrin Fibrinogen Degradation Products03 medical and health sciencesInternal medicineHumansICU Intensive care unitsACE2 Angiotensin converting enzyme-2AgedInflammationLDH Lactate dehydrogenaseSARS-CoV-2 Severe acute respiratory syndrome coronavirus 2CI Confidence intervalbusiness.industryPulmonary embolismCOVID-19AnticoagulantsThrombosisRR Respiratory ratemedicine.diseaseConfidence intervalCHOD CRP concentration + Heart rate + Oxygen saturation + D-dimer levelsSpainHR Hazard RatioCommentarybusinessJournal of Infection
researchProduct

Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

2021

Objective: This study was undertaken to assess the impact of immunosuppressive and immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID-19) in people with multiple sclerosis (PwMS). Methods: We retrospectively collected data of PwMS with suspected or confirmed COVID-19. All the patients had complete follow-up to death or recovery. Severe COVID-19 was defined by a 3-level variable: mild disease not requiring hospitalization versus pneumonia or hospitalization versus intensive care unit (ICU) admission or death. We evaluated baseline characteristics and MS therapies associated with severe COVID-19 by multivariate and propensity score (PS)-weighted ordinal logistic mod…

Male0301 basic medicineDimethyl FumarateNeurodegenerativemultiple sclerosis; coronavirus; pneumoniaSeverity of Illness Indexlaw.inventionImmunosuppressive AgentImmunologic Factor0302 clinical medicineNatalizumablawMonoclonalMultiple Sclerosi80 and overLungHumanizedResearch ArticlesAged 80 and overNatalizumabMiddle AgedIntensive care unitHospitalizationSettore MED/26 - NEUROLOGIAIntensive Care UnitsNeurologyMethylprednisoloneNeurologicalPneumonia & InfluenzaInterferonFemaleImmunosuppressive AgentsResearch ArticleHumanmedicine.drugAdultmedicine.medical_specialtyMusc-19 Study GroupMultiple SclerosisAdolescentClinical SciencesIntensive Care UnitClinical NeurologySettore MED/26Antibodies Monoclonal HumanizedAutoimmune DiseaseAntibodiesYoung Adult03 medical and health sciencesClinical ResearchInternal medicineSeverity of illnessmedicineHumansImmunologic FactorsMortalityAdolescent; Adult; Aged; Aged 80 and over; Antibodies Monoclonal Humanized; COVID-19; Dimethyl Fumarate; Female; Fingolimod Hydrochloride; Hospitalization; Humans; Immunologic Factors; Immunosuppressive Agents; Intensive Care Units; Interferons; Male; Middle Aged; Mortality; Multiple Sclerosis; Natalizumab; SARS-CoV-2; Severity of Illness Index; Young AdultAgedNeurology & NeurosurgeryExpanded Disability Status ScaleFingolimod HydrochlorideSARS-CoV-2business.industryMultiple sclerosisNeurosciencesCOVID-19PneumoniaOdds ratiomedicine.diseaseBrain DisordersGood Health and Well Being030104 developmental biologyOcrelizumabInterferonsNeurology (clinical)business030217 neurology & neurosurgery
researchProduct

Profiles of multidrug-resistant organisms among patients with bacteremia in intensive care units: an international ID-IRI survey

2021

Evaluating trends in antibiotic resistance is a requisite. The study aimed to analyze the profile of multidrug-resistant organisms (MDROs) among hospitalized patients with bacteremia in intensive care units (ICUs) in a large geographical area. This is a 1-month cross-sectional survey for blood-borne pathogens in 57 ICUs from 24 countries with different income levels: lower-middle-income (LMI), upper-middle-income (UMI), and high-income (HI) countries. Multidrug-resistant (MDR), extensively drug-resistant (XDR), or pan-drug-resistant isolates were searched. Logistic regression analysis determined resistance predictors among MDROs. Community-acquired infections were comparable to hospital-acq…

Male0301 basic medicineKlebsiella pneumoniaeDrug ResistanceInfection controlMultidrug resistance0302 clinical medicineMedical microbiologyDrug Resistance Multiple Bacterial80 and overInfection controlMedicine030212 general & internal medicineChildAged 80 and overCross InfectionbiologyMicrobial Sensitivity TestBacterialBacterial InfectionsGeneral MedicineMiddle AgedSciences bio-médicales et agricolesCountriesAnti-Bacterial AgentsAcinetobacter baumanniiEuropeIntensive Care UnitsInfectious DiseasesChild PreschoolFemaleMultipleMicrobiology (medical)Adultmedicine.medical_specialtyAdolescent030106 microbiologyIntensive Care UnitPan-drug resistanceMicrobial Sensitivity TestsInfectionsBacterial InfectionYoung Adult03 medical and health sciencesAntibiotic resistanceIntensive careInternal medicineAnti-Bacterial AgentHumansStewardshipXDRPreschoolAgedCross-Sectional StudieBacteriabusiness.industryInfantbiology.organism_classificationmedicine.diseaseMultiple drug resistanceCross-Sectional StudiesBacteremiabusinessLow- and upper-middle and high income
researchProduct

Effect of antiviral treatment in older patients hospitalized with confirmed influenza

2019

Abstract Seasonal influenza causes significant morbidity and mortality in people aged ≥65 years. Antiviral treatment can reduce complications and disease severity. The objective of this study was to investigate the effect of antiviral treatment in patients aged ≥65 years hospitalized with confirmed influenza in preventing intensive care unit (ICU) admission or death. A retrospective cohort study was carried out in 20 hospitals from seven Spanish regions during 2013–2015 in patients aged ≥65 years. Hospitalized cases of laboratory-confirmed influenza were selected. To assess the association between antiviral treatment and ICU admission or death, the adjusted odds ratios (aOR) and their 95% c…

Male0301 basic medicinemedicine.medical_specialtyHospitalized patients030106 microbiologyLogistic regressionAntiviral AgentsTime-to-Treatmentlaw.invention03 medical and health sciencesOseltamivirOlder patientsAdrenal Cortex HormoneslawVirologyInternal medicineInfluenza HumanHumansMedicineAntiviral treatmentAgedRetrospective StudiesPharmacologybusiness.industryRetrospective cohort studyOdds ratioIntensive care unitConfidence intervalHospitalizationIntensive Care UnitsTreatment Outcome030104 developmental biologyFemalebusinessAntiviral Research
researchProduct

Cerebrospinal fluid pharmacokinetics of ceftaroline in neurosurgical patients with an external ventricular drain

2019

IF 5.217; International audience; BackgroundOwing to its antibacterial properties, ceftaroline could be attractive for prevention or treatment of bacterial post-neurosurgical meningitis/ventriculitis. However, few data are available concerning its meningeal concentrations.ObjectivesTo investigate ceftaroline CSF pharmacokinetics in ICU patients with an external ventricular drain (EVD).MethodsPatients received a single 600 mg dose of ceftaroline as a 1 h intravenous infusion. Blood and CSF samples were collected before and 0.5, 1, 3, 6, 12 and 24 h after the end of the infusion. Concentrations were assayed in plasma and CSF by LC–MS/MS. A two-step compartmental pharmacokinetic analysis was c…

Male0301 basic medicinemedicine.medical_treatmentprotein bindinginfusion proceduresintensive care unitCerebral VentriclesCerebral VentriculitisPostoperative Complications0302 clinical medicineCerebrospinal fluidTandem Mass SpectrometryPharmacology (medical)030212 general & internal medicineInfusions Intravenousintravenous infusion proceduresmeningitisMiddle AgedAnti-Bacterial Agents3. Good healthIntensive Care UnitsInfectious DiseasesAnesthesiaDrainageceftarolineFemalepharmacokineticsMeningitisAdultMicrobiology (medical)VentriculostomyAdolescent030106 microbiologyCmax[SDV.MHEP.CHI]Life Sciences [q-bio]/Human health and pathology/Surgerycerebrospinal fluidMeningitis BacterialYoung Adult03 medical and health sciencesPharmacokineticsavian ventriculitismedicineVentriculitisHumansDistribution (pharmacology)plasmaAgedbacterial post-neurosurgical meningitis/ventriculitisPharmacologybusiness.industryModels Theoreticalmedicine.diseaseneurosurgical proceduresCephalosporinsventriculostomybusinessChromatography LiquidExternal ventricular drainJournal of Antimicrobial Chemotherapy
researchProduct

Mid-regional pro-adrenomedullin predicts poor outcome in non-selected patients admitted to an intensive care unit.

2018

AbstractBackgroundMortality risk and outcome in critically ill patients can be predicted by scoring systems, such as APACHE and SAPS. The identification of prognostic biomarkers, simple to measure upon admission to an intensive care unit (ICU) is an open issue. The aim of this observational study was to assess the prognostic value of plasma mid-regional pro-adrenomedullin (MR-proADM) at ICU admission in non-selected patients in comparison to Acute Physiology and Chronic Health Evaluation II (APACHEII) and Simplified Acute Physiology Score II (SAPSII) scores.MethodsAPACHEII and SAPSII scores were calculated after 24 h from ICU admission. Plasma MR-proADM levels were measured by TRACE-Kryptor…

Male030213 general clinical medicinemedicine.medical_specialtyMultivariate analysisPrognosiMR-proADMClinical BiochemistrySAPSII030204 cardiovascular system & hematologylaw.invention03 medical and health sciencesAdrenomedullin0302 clinical medicinelawPredictive Value of TestsClinical endpointMedicineHumansMortalitySimplified Acute Physiology ScoreAgedAged 80 and overReceiver operating characteristicbusiness.industryBiochemistry (medical)Area under the curveGeneral MedicineOdds ratioMiddle AgedIntensive care unitConfidence intervalIntensive Care UnitsICUEmergency medicineMultivariate AnalysisFemaleAPACHEIIbusinessBiomarkersClinical chemistry and laboratory medicineReferences
researchProduct